DaVita Inc. is a leading provider of kidney care and dialysis services in the United States. The company's mission is to be the trusted partner in improving the quality of life for patients with chronic kidney disease. DaVita Inc. employs a patient-centric strategy, focusing on innovative treatment options and comprehensive care management. With a network of outpatient dialysis centers and a commitment to community health, DaVita Inc. aims to enhance patient outcomes through personalized care, education, and support, while also striving for operational excellence and sustainable growth in the healthcare sector.

DAVITA INC

Berkshire Hathaway, helmed by Warren Buffett, has strategically reduced its stake in DaVita Inc. by selling a total of 750,000 shares between February 14 and 19, 2025, following an earlier sale of 203,091 shares on February 11. This brings Berkshire's total ownership to approximately 35.14 million shares, or 45%, valued...

Berkshire Hathaway Reduces Stake in DaVita Amid Stock Decline and Profit Outlook Concerns

Berkshire Hathaway's recent decision to trim its stake in DaVita highlights growing concerns over the company's profit outlook and rising operational costs. With a significant drop in share value and a cautious market, can DaVita navigate these challenges and regain investor confidence?